Paper723935
Novel cytochrome b system in phagocytic vacuoles of human granulocytes.
Segal AW and 1 other. Nature, 1978. Cited by 293 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Papers, record 723935. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/723935
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytochromes | Major topic |
| Granulomatous Disease, Chronic | Major topic |
| Neutrophils | Major topic |
| Phagocytosis | Major topic |
| Carbon Monoxide | |
| Humans | |
| Vacuoles |
Source PubMed
Cited by81
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 293 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42405795 | Role of NADPH oxidase 2-derived reactive oxygen species in cardiac electrophysiological disorders. | Channels (Austin) | 2026 | https://conductscience.org/library/papers/42405795 | PubMed |
| 42352030 | Molecular Views into the Synthesis and Activation of Flavocytochrome b558 in Phagocytic Cells-Focus on the Role of EROS. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42352030 | PubMed |
| 41020442 | Redox Regulation of Microvascular Physiology and Pathophysiology: Insights into Therapeutic Strategies and Limitations. | Antioxid Redox Signal | 2025 | https://conductscience.org/library/papers/41020442 | PubMed |
| 41009046 | Beyond Antioxidants: How Redox Pathways Shape Cellular Signaling and Disease Outcomes. | Antioxidants (Basel) | 2025 | https://conductscience.org/library/papers/41009046 | PubMed |
| 40694338 | Central memory T cells with key TCR repertoires and gene expression profiles dominate influenza CD8+ T cell pools across the human lifespan. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40694338 | PubMed |
| 39814410 | NADPH oxidases: redox regulation of cell homeostasis and disease. | Physiol Rev | 2025 | https://conductscience.org/library/papers/39814410 | PubMed |
| 39710133 | Neutrophil NADPH oxidase promotes bacterial eradication and regulates NF-κB-Mediated inflammation via NRF2 signaling during urinary tract infections. | Mucosal Immunol | 2025 | https://conductscience.org/library/papers/39710133 | PubMed |
| 39313896 | Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review. | Curr Vasc Pharmacol | 2025 | https://conductscience.org/library/papers/39313896 | PubMed |
| 39005504 | Clinical presentation, diagnosis, and treatment of chronic granulomatous disease. | Front Pediatr | 2024 | https://conductscience.org/library/papers/39005504 | PubMed |
| 38805284 | Structural basis for EROS binding to human phagocyte NADPH oxidase NOX2. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/38805284 | PubMed |
| 38640072 | X-ray structure and enzymatic study of a bacterial NADPH oxidase highlight the activation mechanism of eukaryotic NOX. | Elife | 2024 | https://conductscience.org/library/papers/38640072 | PubMed |
| 38397817 | NADPH Oxidase 3: Beyond the Inner Ear. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38397817 | PubMed |
| 38201509 | Inflammation-Associated Cytotoxic Agents in Tumorigenesis. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38201509 | PubMed |
| 36831253 | Early Detection Is the Best Prevention-Characterization of Oxidative Stress in Diabetes Mellitus and Its Consequences on the Cardiovascular System. | Cells | 2023 | https://conductscience.org/library/papers/36831253 | PubMed |
| 36769331 | Host-Derived Cytotoxic Agents in Chronic Inflammation and Disease Progression. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769331 | PubMed |
| 34887759 | Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson's Disease. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34887759 | PubMed |
| 34539670 | Beyond the Extra Respiration of Phagocytosis: NADPH Oxidase 2 in Adaptive Immunity and Inflammation. | Front Immunol | 2021 | https://conductscience.org/library/papers/34539670 | PubMed |
| 34205998 | NADPH Oxidases (NOX): An Overview from Discovery, Molecular Mechanisms to Physiology and Pathology. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/34205998 | PubMed |
| 34067602 | Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34067602 | PubMed |
| 33503855 | Novel and Converging Ways of NOX2 and SOD3 in Trafficking and Redox Signaling in Macrophages. | Antioxidants (Basel) | 2021 | https://conductscience.org/library/papers/33503855 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MT-CYB | 4519 | PubTator's text mining | https://conductscience.org/library/genes/4519 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/723935
GET https://conductscience.org/api/papers/v1/723935/cited_by?page=2